English
简体中文
Total: £ 56.28
Published Date: 2025-04-23 | Pages: 104 | Tables: 108 | Pharma & Healthcare
The global Brucellosis Vaccines market size was US$ 11.8 million in 2024 and is forecast to a readjusted size of US$ 15.2 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
Global Brucellosis Vaccines main players are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, etc. Global top four manufacturers hold a share above 35%. China is the largest market, with a share about 30%.
The global Brucellosis Vaccines market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
By Type: (Dominant Segment vs High-Margin Innovation)
S19 Vaccine
RB51 Vaccine Strain
By Application: (Core Demand Driver vs Emerging Opportunity)
Cattle
Sheep
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Jinyu in Europe)
- Emerging Product Trends: S19 Vaccine adoption vs. RB51 Vaccine Strain premiumization
- Demand-Side Dynamics: Cattle growth in China vs. Sheep potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Brucellosis Vaccines market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., RB51 Vaccine Strain in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Sheep in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., S19 Vaccine dominance in Europe vs. RB51 Vaccine Strain demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Brucellosis Vaccines Product Scope
1.2 Brucellosis Vaccines by Type
1.2.1 Global Brucellosis Vaccines Sales by Type (2020 & 2024 & 2031)
1.2.2 S19 Vaccine
1.2.3 RB51 Vaccine Strain
1.3 Brucellosis Vaccines by Application
1.3.1 Global Brucellosis Vaccines Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Others
1.4 Global Brucellosis Vaccines Market Estimates and Forecasts (2020-2031)
1.4.1 Global Brucellosis Vaccines Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Brucellosis Vaccines Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Brucellosis Vaccines Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Brucellosis Vaccines Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Brucellosis Vaccines Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Brucellosis Vaccines Sales Market Share by Region (2020-2025)
2.2.2 Global Brucellosis Vaccines Revenue Market Share by Region (2020-2025)
2.3 Global Brucellosis Vaccines Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Brucellosis Vaccines Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Brucellosis Vaccines Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Brucellosis Vaccines Market Size and Prospective (2020-2031)
2.4.2 Europe Brucellosis Vaccines Market Size and Prospective (2020-2031)
2.4.3 China Brucellosis Vaccines Market Size and Prospective (2020-2031)
2.4.4 Japan Brucellosis Vaccines Market Size and Prospective (2020-2031)
2.4.5 India Brucellosis Vaccines Market Size and Prospective (2020-2031)
2.4.6 South America Brucellosis Vaccines Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Brucellosis Vaccines Historic Market Review by Type (2020-2025)
3.1.1 Global Brucellosis Vaccines Sales by Type (2020-2025)
3.1.2 Global Brucellosis Vaccines Revenue by Type (2020-2025)
3.1.3 Global Brucellosis Vaccines Price by Type (2020-2025)
3.2 Global Brucellosis Vaccines Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Brucellosis Vaccines Sales Forecast by Type (2026-2031)
3.2.2 Global Brucellosis Vaccines Revenue Forecast by Type (2026-2031)
3.2.3 Global Brucellosis Vaccines Price Forecast by Type (2026-2031)
3.3 Different Types Brucellosis Vaccines Representative Players
4 Global Market Size by Application
4.1 Global Brucellosis Vaccines Historic Market Review by Application (2020-2025)
4.1.1 Global Brucellosis Vaccines Sales by Application (2020-2025)
4.1.2 Global Brucellosis Vaccines Revenue by Application (2020-2025)
4.1.3 Global Brucellosis Vaccines Price by Application (2020-2025)
4.2 Global Brucellosis Vaccines Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Brucellosis Vaccines Sales Forecast by Application (2026-2031)
4.2.2 Global Brucellosis Vaccines Revenue Forecast by Application (2026-2031)
4.2.3 Global Brucellosis Vaccines Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Brucellosis Vaccines Application
5 Competition Landscape by Players
5.1 Global Brucellosis Vaccines Sales by Players (2020-2025)
5.2 Global Top Brucellosis Vaccines Players by Revenue (2020-2025)
5.3 Global Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucellosis Vaccines as of 2024)
5.4 Global Brucellosis Vaccines Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Brucellosis Vaccines, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Brucellosis Vaccines, Product Type & Application
5.7 Global Key Manufacturers of Brucellosis Vaccines, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Brucellosis Vaccines Sales by Company
6.1.1.1 North America Brucellosis Vaccines Sales by Company (2020-2025)
6.1.1.2 North America Brucellosis Vaccines Revenue by Company (2020-2025)
6.1.2 North America Brucellosis Vaccines Sales Breakdown by Type (2020-2025)
6.1.3 North America Brucellosis Vaccines Sales Breakdown by Application (2020-2025)
6.1.4 North America Brucellosis Vaccines Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Brucellosis Vaccines Sales by Company
6.2.1.1 Europe Brucellosis Vaccines Sales by Company (2020-2025)
6.2.1.2 Europe Brucellosis Vaccines Revenue by Company (2020-2025)
6.2.2 Europe Brucellosis Vaccines Sales Breakdown by Type (2020-2025)
6.2.3 Europe Brucellosis Vaccines Sales Breakdown by Application (2020-2025)
6.2.4 Europe Brucellosis Vaccines Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Brucellosis Vaccines Sales by Company
6.3.1.1 China Brucellosis Vaccines Sales by Company (2020-2025)
6.3.1.2 China Brucellosis Vaccines Revenue by Company (2020-2025)
6.3.2 China Brucellosis Vaccines Sales Breakdown by Type (2020-2025)
6.3.3 China Brucellosis Vaccines Sales Breakdown by Application (2020-2025)
6.3.4 China Brucellosis Vaccines Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Brucellosis Vaccines Sales by Company
6.4.1.1 Japan Brucellosis Vaccines Sales by Company (2020-2025)
6.4.1.2 Japan Brucellosis Vaccines Revenue by Company (2020-2025)
6.4.2 Japan Brucellosis Vaccines Sales Breakdown by Type (2020-2025)
6.4.3 Japan Brucellosis Vaccines Sales Breakdown by Application (2020-2025)
6.4.4 Japan Brucellosis Vaccines Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Brucellosis Vaccines Sales by Company
6.5.1.1 India Brucellosis Vaccines Sales by Company (2020-2025)
6.5.1.2 India Brucellosis Vaccines Revenue by Company (2020-2025)
6.5.2 India Brucellosis Vaccines Sales Breakdown by Type (2020-2025)
6.5.3 India Brucellosis Vaccines Sales Breakdown by Application (2020-2025)
6.5.4 India Brucellosis Vaccines Major Customer
6.5.5 India Market Trend and Opportunities
6.6 South America Market: Players, Segments, Downstream and Major Customers
6.6.1 South America Brucellosis Vaccines Sales by Company
6.6.1.1 South America Brucellosis Vaccines Sales by Company (2020-2025)
6.6.1.2 South America Brucellosis Vaccines Revenue by Company (2020-2025)
6.6.2 South America Brucellosis Vaccines Sales Breakdown by Type (2020-2025)
6.6.3 South America Brucellosis Vaccines Sales Breakdown by Application (2020-2025)
6.6.4 South America Brucellosis Vaccines Major Customer
6.6.5 South America Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Jinyu
7.1.1 Jinyu Company Information
7.1.2 Jinyu Business Overview
7.1.3 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Jinyu Brucellosis Vaccines Products Offered
7.1.5 Jinyu Recent Development
7.2 Colorado Serum
7.2.1 Colorado Serum Company Information
7.2.2 Colorado Serum Business Overview
7.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Colorado Serum Brucellosis Vaccines Products Offered
7.2.5 Colorado Serum Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Information
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Boehringer Ingelheim Brucellosis Vaccines Products Offered
7.3.5 Boehringer Ingelheim Recent Development
7.4 Biogenesis-Bago
7.4.1 Biogenesis-Bago Company Information
7.4.2 Biogenesis-Bago Business Overview
7.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Biogenesis-Bago Brucellosis Vaccines Products Offered
7.4.5 Biogenesis-Bago Recent Development
7.5 Vetal Company
7.5.1 Vetal Company Company Information
7.5.2 Vetal Company Business Overview
7.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Vetal Company Brucellosis Vaccines Products Offered
7.5.5 Vetal Company Recent Development
7.6 CZ Veterinaria
7.6.1 CZ Veterinaria Company Information
7.6.2 CZ Veterinaria Business Overview
7.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.6.4 CZ Veterinaria Brucellosis Vaccines Products Offered
7.6.5 CZ Veterinaria Recent Development
7.7 SYVA Laboratorios
7.7.1 SYVA Laboratorios Company Information
7.7.2 SYVA Laboratorios Business Overview
7.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.7.4 SYVA Laboratorios Brucellosis Vaccines Products Offered
7.7.5 SYVA Laboratorios Recent Development
7.8 Indian Immunologicals
7.8.1 Indian Immunologicals Company Information
7.8.2 Indian Immunologicals Business Overview
7.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Indian Immunologicals Brucellosis Vaccines Products Offered
7.8.5 Indian Immunologicals Recent Development
7.9 Qilu
7.9.1 Qilu Company Information
7.9.2 Qilu Business Overview
7.9.3 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Qilu Brucellosis Vaccines Products Offered
7.9.5 Qilu Recent Development
7.10 Tecnovax
7.10.1 Tecnovax Company Information
7.10.2 Tecnovax Business Overview
7.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Tecnovax Brucellosis Vaccines Products Offered
7.10.5 Tecnovax Recent Development
7.11 Hester Biosciences
7.11.1 Hester Biosciences Company Information
7.11.2 Hester Biosciences Business Overview
7.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Hester Biosciences Brucellosis Vaccines Products Offered
7.11.5 Hester Biosciences Recent Development
7.12 Zoetis
7.12.1 Zoetis Company Information
7.12.2 Zoetis Business Overview
7.12.3 Zoetis Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Zoetis Brucellosis Vaccines Products Offered
7.12.5 Zoetis Recent Development
7.13 Onderstepoort Biological
7.13.1 Onderstepoort Biological Company Information
7.13.2 Onderstepoort Biological Business Overview
7.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Onderstepoort Biological Brucellosis Vaccines Products Offered
7.13.5 Onderstepoort Biological Recent Development
7.14 Instituto Rosenbusch
7.14.1 Instituto Rosenbusch Company Information
7.14.2 Instituto Rosenbusch Business Overview
7.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Instituto Rosenbusch Brucellosis Vaccines Products Offered
7.14.5 Instituto Rosenbusch Recent Development
7.15 Ceva Sante Animale
7.15.1 Ceva Sante Animale Company Information
7.15.2 Ceva Sante Animale Business Overview
7.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Ceva Sante Animale Brucellosis Vaccines Products Offered
7.15.5 Ceva Sante Animale Recent Development
7.16 Calier & Biologicos Laverlam
7.16.1 Calier & Biologicos Laverlam Company Information
7.16.2 Calier & Biologicos Laverlam Business Overview
7.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Products Offered
7.16.5 Calier & Biologicos Laverlam Recent Development
7.17 Biovet
7.17.1 Biovet Company Information
7.17.2 Biovet Business Overview
7.17.3 Biovet Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Biovet Brucellosis Vaccines Products Offered
7.17.5 Biovet Recent Development
8 Brucellosis Vaccines Manufacturing Cost Analysis
8.1 Brucellosis Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Brucellosis Vaccines
8.4 Brucellosis Vaccines Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Brucellosis Vaccines Distributors List
9.3 Brucellosis Vaccines Customers
10 Brucellosis Vaccines Market Dynamics
10.1 Brucellosis Vaccines Industry Trends
10.2 Brucellosis Vaccines Market Drivers
10.3 Brucellosis Vaccines Market Challenges
10.4 Brucellosis Vaccines Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Brucellosis Vaccines Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Brucellosis Vaccines Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Brucellosis Vaccines Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Brucellosis Vaccines Sales (M Doses) by Region (2020-2025)
Table 5. Global Brucellosis Vaccines Sales Market Share by Region (2020-2025)
Table 6. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Brucellosis Vaccines Revenue Share by Region (2020-2025)
Table 8. Global Brucellosis Vaccines Sales (M Doses) Forecast by Region (2026-2031)
Table 9. Global Brucellosis Vaccines Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Brucellosis Vaccines Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Brucellosis Vaccines Revenue Share Forecast by Region (2026-2031)
Table 12. Global Brucellosis Vaccines Sales by Type (M Doses) & (2020-2025)
Table 13. Global Brucellosis Vaccines Sales Share by Type (2020-2025)
Table 14. Global Brucellosis Vaccines Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Brucellosis Vaccines Price by Type (USD/K Doses) & (2020-2025)
Table 16. Global Brucellosis Vaccines Sales by Type (M Doses) & (2026-2031)
Table 17. Global Brucellosis Vaccines Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Brucellosis Vaccines Price by Type (USD/K Doses) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Brucellosis Vaccines Sales by Application (M Doses) & (2020-2025)
Table 21. Global Brucellosis Vaccines Sales Share by Application (2020-2025)
Table 22. Global Brucellosis Vaccines Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Brucellosis Vaccines Price by Application (USD/K Doses) & (2020-2025)
Table 24. Global Brucellosis Vaccines Sales by Application (M Doses) & (2026-2031)
Table 25. Global Brucellosis Vaccines Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Brucellosis Vaccines Price by Application (USD/K Doses) & (2026-2031)
Table 27. New Sources of Growth in Brucellosis Vaccines Application
Table 28. Global Brucellosis Vaccines Sales by Company (M Doses) & (2020-2025)
Table 29. Global Brucellosis Vaccines Sales Share by Company (2020-2025)
Table 30. Global Brucellosis Vaccines Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Brucellosis Vaccines Revenue Share by Company (2020-2025)
Table 32. Global Brucellosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucellosis Vaccines as of 2024)
Table 33. Global Market Brucellosis Vaccines Average Price by Company (USD/K Doses) & (2020-2025)
Table 34. Global Key Manufacturers of Brucellosis Vaccines, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Brucellosis Vaccines, Product Type & Application
Table 36. Global Key Manufacturers of Brucellosis Vaccines, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Brucellosis Vaccines Sales by Company (2020-2025) & (M Doses)
Table 39. North America Brucellosis Vaccines Sales Market Share by Company (2020-2025)
Table 40. North America Brucellosis Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Brucellosis Vaccines Revenue Market Share by Company (2020-2025)
Table 42. North America Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 43. North America Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Table 44. North America Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 45. North America Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Table 46. Europe Brucellosis Vaccines Sales by Company (2020-2025) & (M Doses)
Table 47. Europe Brucellosis Vaccines Sales Market Share by Company (2020-2025)
Table 48. Europe Brucellosis Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Brucellosis Vaccines Revenue Market Share by Company (2020-2025)
Table 50. Europe Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 51. Europe Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Table 52. Europe Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 53. Europe Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Table 54. China Brucellosis Vaccines Sales by Company (2020-2025) & (M Doses)
Table 55. China Brucellosis Vaccines Sales Market Share by Company (2020-2025)
Table 56. China Brucellosis Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Brucellosis Vaccines Revenue Market Share by Company (2020-2025)
Table 58. China Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 59. China Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Table 60. China Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 61. China Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Table 62. Japan Brucellosis Vaccines Sales by Company (2020-2025) & (M Doses)
Table 63. Japan Brucellosis Vaccines Sales Market Share by Company (2020-2025)
Table 64. Japan Brucellosis Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Brucellosis Vaccines Revenue Market Share by Company (2020-2025)
Table 66. Japan Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 67. Japan Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Table 68. Japan Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 69. Japan Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Table 70. India Brucellosis Vaccines Sales by Company (2020-2025) & (M Doses)
Table 71. India Brucellosis Vaccines Sales Market Share by Company (2020-2025)
Table 72. India Brucellosis Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Brucellosis Vaccines Revenue Market Share by Company (2020-2025)
Table 74. India Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 75. India Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Table 76. India Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 77. India Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Table 78. South America Brucellosis Vaccines Sales by Company (2020-2025) & (M Doses)
Table 79. South America Brucellosis Vaccines Sales Market Share by Company (2020-2025)
Table 80. South America Brucellosis Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 81. South America Brucellosis Vaccines Revenue Market Share by Company (2020-2025)
Table 82. South America Brucellosis Vaccines Sales by Type (2020-2025) & (M Doses)
Table 83. South America Brucellosis Vaccines Sales Market Share by Type (2020-2025)
Table 84. South America Brucellosis Vaccines Sales by Application (2020-2025) & (M Doses)
Table 85. South America Brucellosis Vaccines Sales Market Share by Application (2020-2025)
Table 86. Jinyu Company Information
Table 87. Jinyu Description and Business Overview
Table 88. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 89. Jinyu Brucellosis Vaccines Product
Table 90. Jinyu Recent Development
Table 91. Colorado Serum Company Information
Table 92. Colorado Serum Description and Business Overview
Table 93. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 94. Colorado Serum Brucellosis Vaccines Product
Table 95. Colorado Serum Recent Development
Table 96. Boehringer Ingelheim Company Information
Table 97. Boehringer Ingelheim Description and Business Overview
Table 98. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 99. Boehringer Ingelheim Brucellosis Vaccines Product
Table 100. Boehringer Ingelheim Recent Development
Table 101. Biogenesis-Bago Company Information
Table 102. Biogenesis-Bago Description and Business Overview
Table 103. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 104. Biogenesis-Bago Brucellosis Vaccines Product
Table 105. Biogenesis-Bago Recent Development
Table 106. Vetal Company Company Information
Table 107. Vetal Company Description and Business Overview
Table 108. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 109. Vetal Company Brucellosis Vaccines Product
Table 110. Vetal Company Recent Development
Table 111. CZ Veterinaria Company Information
Table 112. CZ Veterinaria Description and Business Overview
Table 113. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 114. CZ Veterinaria Brucellosis Vaccines Product
Table 115. CZ Veterinaria Recent Development
Table 116. SYVA Laboratorios Company Information
Table 117. SYVA Laboratorios Description and Business Overview
Table 118. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 119. SYVA Laboratorios Brucellosis Vaccines Product
Table 120. SYVA Laboratorios Recent Development
Table 121. Indian Immunologicals Company Information
Table 122. Indian Immunologicals Description and Business Overview
Table 123. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 124. Indian Immunologicals Brucellosis Vaccines Product
Table 125. Indian Immunologicals Recent Development
Table 126. Qilu Company Information
Table 127. Qilu Description and Business Overview
Table 128. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 129. Qilu Brucellosis Vaccines Product
Table 130. Qilu Recent Development
Table 131. Tecnovax Company Information
Table 132. Tecnovax Description and Business Overview
Table 133. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 134. Tecnovax Brucellosis Vaccines Product
Table 135. Tecnovax Recent Development
Table 136. Hester Biosciences Company Information
Table 137. Hester Biosciences Description and Business Overview
Table 138. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 139. Hester Biosciences Brucellosis Vaccines Product
Table 140. Hester Biosciences Recent Development
Table 141. Zoetis Company Information
Table 142. Zoetis Description and Business Overview
Table 143. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 144. Zoetis Brucellosis Vaccines Product
Table 145. Zoetis Recent Development
Table 146. Onderstepoort Biological Company Information
Table 147. Onderstepoort Biological Description and Business Overview
Table 148. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 149. Onderstepoort Biological Brucellosis Vaccines Product
Table 150. Onderstepoort Biological Recent Development
Table 151. Instituto Rosenbusch Company Information
Table 152. Instituto Rosenbusch Description and Business Overview
Table 153. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 154. Instituto Rosenbusch Brucellosis Vaccines Product
Table 155. Instituto Rosenbusch Recent Development
Table 156. Ceva Sante Animale Company Information
Table 157. Ceva Sante Animale Description and Business Overview
Table 158. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 159. Ceva Sante Animale Brucellosis Vaccines Product
Table 160. Ceva Sante Animale Recent Development
Table 161. Calier & Biologicos Laverlam Company Information
Table 162. Calier & Biologicos Laverlam Description and Business Overview
Table 163. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 164. Calier & Biologicos Laverlam Brucellosis Vaccines Product
Table 165. Calier & Biologicos Laverlam Recent Development
Table 166. Biovet Company Information
Table 167. Biovet Description and Business Overview
Table 168. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 169. Biovet Brucellosis Vaccines Product
Table 170. Biovet Recent Development
Table 171. Production Base and Market Concentration Rate of Raw Material
Table 172. Key Suppliers of Raw Materials
Table 173. Brucellosis Vaccines Distributors List
Table 174. Brucellosis Vaccines Customers List
Table 175. Brucellosis Vaccines Market Trends
Table 176. Brucellosis Vaccines Market Drivers
Table 177. Brucellosis Vaccines Market Challenges
Table 178. Brucellosis Vaccines Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Brucellosis Vaccines Product Picture
Figure 2. Global Brucellosis Vaccines Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Brucellosis Vaccines Sales Market Share by Type in 2024 & 2031
Figure 4. S19 Vaccine Product Picture
Figure 5. RB51 Vaccine Strain Product Picture
Figure 6. Global Brucellosis Vaccines Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Brucellosis Vaccines Sales Market Share by Application in 2024 & 2031
Figure 8. Cattle Examples
Figure 9. Sheep Examples
Figure 10. Others Examples
Figure 11. Global Brucellosis Vaccines Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Brucellosis Vaccines Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Brucellosis Vaccines Sales (M Doses) Growth Rate (2020-2031)
Figure 14. Global Brucellosis Vaccines Price Trends Growth Rate (2020-2031) & (USD/K Doses)
Figure 15. Brucellosis Vaccines Report Years Considered
Figure 16. Global Market Brucellosis Vaccines Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Brucellosis Vaccines Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Brucellosis Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Brucellosis Vaccines Sales (M Doses) Growth Rate (2020-2031)
Figure 20. Europe Brucellosis Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Brucellosis Vaccines Sales (M Doses) Growth Rate (2020-2031)
Figure 22. China Brucellosis Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Brucellosis Vaccines Sales (M Doses) Growth Rate (2020-2031)
Figure 24. Japan Brucellosis Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Brucellosis Vaccines Sales (M Doses) Growth Rate (2020-2031)
Figure 26. India Brucellosis Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. India Brucellosis Vaccines Sales (M Doses) Growth Rate (2020-2031)
Figure 28. South America Brucellosis Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 29. South America Brucellosis Vaccines Sales (M Doses) Growth Rate (2020-2031)
Figure 30. Global Brucellosis Vaccines Revenue Share by Type (2020-2025)
Figure 31. Global Brucellosis Vaccines Sales Share by Type (2026-2031)
Figure 32. Global Brucellosis Vaccines Revenue Share by Type (2026-2031)
Figure 33. Global Brucellosis Vaccines Revenue Share by Application (2020-2025)
Figure 34. Global Brucellosis Vaccines Revenue Growth Rate by Application in 2020 & 2024
Figure 35. Global Brucellosis Vaccines Sales Share by Application (2026-2031)
Figure 36. Global Brucellosis Vaccines Revenue Share by Application (2026-2031)
Figure 37. Global Brucellosis Vaccines Sales Share by Company (2024)
Figure 38. Global Brucellosis Vaccines Revenue Share by Company (2024)
Figure 39. Global 5 Largest Brucellosis Vaccines Players Market Share by Revenue in Brucellosis Vaccines: 2020 & 2024
Figure 40. Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 41. Manufacturing Cost Structure of Brucellosis Vaccines
Figure 42. Manufacturing Process Analysis of Brucellosis Vaccines
Figure 43. Brucellosis Vaccines Industrial Chain
Figure 44. Channels of Distribution (Direct Vs Distribution)
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
